Global Genomic Data Analysis and Interpretation Market - GLOBAL:2021

Market Report Coverage :
Start Year : 2020 - Forecast Year : 2030 - Start Value : $797.9 Million in 2020 - Forecast Value : $2,109.0 Million by 2030 - CAGR % : 0.1%
Description :
Market Report Coverage - Genomic Data Analysis and InterpretationMarket Segmentation• Product – Software and Services (License and Maintenance)• Genomic Platform – Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and Other Genomic Platforms• Applications – Research (Omics-Data Analysis, Population Sequencing, Annotation and Gene Expression, and Other Research Applications) and Clinical (Oncology, Rare Diseases, Infectious diseases, Sexual and Reproductive Health, and Other Clinical Applications)• End User – Research and Academic Institutions, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostic Laboratories, Contract Research Organizations, Forensic Laboratories, and Other End UsersRegional Segmentation• North America – U.S. and Canada• Europe – Germany, U.K., France, Italy, Spain, Netherlands, and Rest-of-Europe• Asia-Pacific – China, Japan, India, Australia, South Korea, and Rest-of-Asia-Pacific• Latin America – Brazil, Mexico, and Rest-of-Latin America• Rest-of-the-WorldGrowth Drivers• Decreasing Cost of Sequencing• Global Increase in Cancer Prevalence• Increasing Number of Population Genomics InitiativeMarket Challenges• Lack of High Complexity Genomic Testing Centers in High Potential Markets• Challenges Pertaining to Genomic Data Storage• Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic CapabilitiesMarket Opportunities• Massive Scope for the Adoption of Genomic Data Analysis Software in the Emerging Nations• Novel Diagnostic ApplicationsKey Companies Profiled10x Genomics, Inc., Agilent Technologies, Inc., ASURAGEN INC., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Bio-Rad Laboratories, Inc., DNASTAR, F. Hoffmann-La Roche Ltd., Golden Helix, Inc., Illumina, Inc., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., Partek Inc., QIAGEN N.V., SoftGenetics LLC, and Thermo Fisher Scientific Inc.Key Questions Answered in this Report:• How is genomic data analysis and interpretation revolutionizing the field of research and diagnostics?• What are the major market drivers, challenges, and opportunities in the global genomic data analysis and interpretation market?• What are the underlying structures resulting in the emerging trends within the global genomic data analysis and interpretation market?• How the COVID-19 pandemic impacted the genomic data analysis and interpretation landscape?• What are the key development strategies which are being implemented by the major players in order to sustain in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to genomics?• What are the potential entry barriers expected to be faced by the companies willing to enter in a particular region? • How is each segment of the market expected to grow during the forecast period from 2020 to 2030, and what is the anticipated revenue to be generated by each of the segments? Following are the segments: o Product Type (Software and Services) o Genomic Platform (NGS, PCR, Microarray, and Others) o Application (Research and Clinical) o End User (Research and Academic Institutions, Biotechnology and Pharmaceutical Companies, Corporate Research Organizations, Hospitals and Diagnostic Laboratories, Forensic Laboratories, and Others) o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)• What are the growth opportunities for the companies in the region of their operation?• Who are the leading players with significant offerings to the global genomic data analysis and interpretation market? What is the expected market dominance for each of these leading players?• Which companies are anticipated to be highly disruptive in the future and why?• What are the current unmet needs that are being faced?Market OverviewHealthcare experts at BIS have found genomic data analysis and interpretation industry to be one of the most rapidly evolving and dynamic markets and the global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030. The market is driven by certain factors, which include decreasing cost of sequencing, global increase in cancer prevalence, and increasing number of population genomics initiative, among others, are fueling the growth of the global genomic data analysis and interpretation market.The market is favored by the developments in the field of genomics and bioinformatics. Currently, the genomic data analysis and interpretation industry is witnessing an upsurge due to the growing number of genomic research initiatives being undertaken by the developing and developed countries coupled with the decreasing cost of sequencing, resulting in the high demand for software solutions for genomic data analysis. Additionally, high adoption of sequencing instruments by the researchers and clinicians, coupled with the growing prevalence of complex diseases, such as cancer, are some of the critical factors expected to bolster the market growth.Furthermore, biotechnology companies are focusing on the development of robust genomic data analysis software solutions for a wide range of clinical applications to support clinicians in conducting an in-depth analysis.Within the research report, the market is segmented on the basis of product, genomic platform, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.Competitive LandscapeThe exponential rise in the number of cases associated with cancer has created a buzz among the biotechnology companies to further invest in the development of reliable genomic software solutions for data analysis, further aiding clinicians to offer precision oncology treatments. Due to the presence of a diverse product portfolio and intense market penetration, Thermo Fisher Scientific Inc. has been a pioneer in this field and has been a significant competitor in this market.On the basis of region, North America holds the largest share of the genomic data analysis and interpretation market due to high infusion of funding from the government organizations for conducting research on genomics and bioinformatics, rising prevalence of cancer, growing awareness about precision medicine, and decreasing cost of sequencing, among others. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period, 2020-2030.
Countries Covered :
North America U.S. CanadaEurope Germany Italy France Spain U.K. Netherlands Rest-of-EuropeAsia-Pacific China India Australia South Korea Japan Rest-of-Asia-PacificLatin America Brazil Mexico Rest-of-Latin AmericaRest-of-the-Word
Keywords :
Genomic Data Analysis and Interpretation, Genomic Data Analysis, Genomic Interpretation, Next-Generation Sequencing, Polymerase Chain Reaction, Genomic Data Analysis and Interpretation Market, Genomic Data Analysis and Interpretation Report, Genomic Data Analysis and Interpretation Industry, Genomic Data Analysis and Interpretation Market Forecast, Genomic Data Analysis and Interpretation Trends, Genomic Data Analysis and Interpretation Products, Genomic Data Analysis and Interpretation Applications, Genomic Data Analysis and Interpretation Technology, Genomic Data Analysis and Interpretation Companies, Genomic Data Analysis and Interpretation Market Analysis, Genomic Data Analysis and Interpretation Industry Analysis, What is Genomic Data Analysis and Interpretation Market, What are Genomic Data Analysis and Interpretation Market, Genomic Data Analysis Market, Genomic Data Analysis Report, Genomic Data Analysis Industry, Genomic Data Analysis Market Forecast, Genomic Data Analysis Trends, Genomic Data Analysis Products, Genomic Data Analysis Applications, Genomic Data Analysis Technology, Genomic Data Analysis Companies, Genomic Data Analysis Market Analysis, Genomic Data Analysis Industry Analysis, What is Genomic Data Analysis Market, What are Genomic Data Analysis Market, Genomic Data Interpretation Market, Genomic Data Interpretation Report, Genomic Data Interpretation Industry, Genomic Data Interpretation Market Forecast, Genomic Data Interpretation Trends, Genomic Data Interpretation Products, Genomic Data Interpretation Applications, Genomic Data Interpretation Technology, Genomic Data Interpretation Companies, Genomic Data Interpretation Market Analysis, Genomic Data Interpretation Industry Analysis, What is Genomic Data Interpretation Market, What are Genomic Data Interpretation Market, Genomic Data Analysis and Interpretation Market by Product Type, Genomic Data Analysis and Interpretation Market by Genomic Platform, Genomic Data Analysis and Interpretation Market by Application, Genomic Data Analysis and Interpretation Market by Region, Genomic Data Analysis and Interpretation Market by End User, North America Genomic Data Analysis and Interpretation Market, Europe Genomic Data Analysis and Interpretation Market, Asia-Pacific Genomic Data Analysis and Interpretation Market
Press Release :
The global genomic data analysis and interpretation market is projected to reach $2.10 billion by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 10.21% between 2020 and 2030.The comprehensive study of the global genomic data analysis and interpretation market by BIS Research extensively covers the following:• Market numbers on micro-segments that are influencing the market • More than 150 products present in the market• Over 30 brands evaluated • Market share analysis for more than 20 product categories• End-user preference data for over 50 end users• Detailed global and regional market share analysis including the scrutiny of more than 14 countries • Study of data of more than 30 companiesBesides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and a visual dashboard of 150+ products. BIS Research study indicates that decreasing cost of sequencing, global increase in cancer prevalence, and increasing number of population genomics initiative, among others, are fueling the growth of the global genomic data analysis and interpretation market. The market intelligence by BIS Research additionally throws a spotlight on the opportunities existing in the market, such as massive scope for the adoption of genomic data analysis software in the emerging nations and novel diagnostic applications, among others.To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include types of products, genomic platforms, applications, end users, and regions. The application and the region segment have been further sub-segmented to offer an in-depth analysis of the global genomic data analysis and interpretation market.The product and ecosystem analysis of the global market include data analysis on the satisfaction level of different pricing analysis of preferred software solutions. Pertaining to the market segmentation, the product segment is segmented into software and services. The services sub-segment under the product segment has been further classified as licenses and maintenance. The genomic platform segment has been segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, and other platforms. The application segment has been segmented into research and clinical. Research applications have been further segmented into the omics-data analysis, population genomics, annotation and gene expression, and other research applications. The omics-data analysis sub-segment has been further segmented into transcriptomics, microbiomics, proteomics, and others. Additionally, the clinical applications have been further segmented into oncology, rare diseases, infectious diseases, sexual and reproductive health, and other applications. Furthermore, the end user segment has been further segmented into research and academic institutions, biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations, forensic laboratories, and other end users.Emphasizing the dominance of the North America region in the global genomic data analysis and interpretation market in 2020 and 2030, Nitish Singh, Analyst at BIS Research, states, " In North America, several emerging and legacy companies are focusing on expanding their respective genomic data analysis software portfolio and are actively involved in developing software new applications, particularly for clinical use. Moreover, a significant infusion of funds for conducting genomic research for enabling precision medicine coupled with a significant decrease in the cost of sequencing has massively promoted the adoption of robust genomic software solutions for data analysis by various end users, further supporting the market growth in the region.”Key insights are drawn from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The key players profiled in the report include 10x Genomics, Inc., Agilent Technologies, Inc., ASURAGEN INC., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Bio-Rad Laboratories, Inc., DNASTAR, F. Hoffmann-La Roche Ltd., Golden Helix, Inc., Illumina, Inc., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., Partek Inc., QIAGEN N.V., SoftGenetics LLC, and Thermo Fisher Scientific Inc.The study also offers strategic recommendations that can help organizations in tracking various products and trends that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.Who should buy this report?• Developers and manufacturers of robust genomics software solutions, operating in the field of genomics. • Emerging companies in the field of genomic data analysis and interpretation to assess the market situation.How can market intelligence on genomic data analysis and interpretation add value to an organization’s decision-making process?• Aid in product (software) development • Help in targeting a segment for launching a new software • Offer go to market access strategies • Support in diversifying the product portfolio basis risk and progression of underlying genomic technologies • Help in analyzing specifications• Aid in understanding the end-user landscape• Gain holistic views pertaining to the regions and understand the market potential of the countries.• Support in analyzing the competitive landscape to gain an understanding of the business strategies incorporated by the companiesInsightful Questions Covered to Enable Companies take Strategic Decisions• How is genomic data analysis and interpretation revolutionizing the field of research and diagnostics?• What are the major market drivers, challenges, and opportunities in the global genomic data analysis and interpretation market?• What are the underlying structures resulting in the emerging trends within the global genomic data analysis and interpretation market?• How the COVID-19 pandemic impacted the genomic data analysis and interpretation landscape?• What are the key development strategies which are being implemented by the major players in order to sustain in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to genomics?• What are the potential entry barriers expected to be faced by the companies willing to enter in a particular region? • How is each segment of the market expected to grow during the forecast period from 2020 to 2030, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:o Product Type (Software and Services)o Genomic Platform (NGS, PCR, Microarray, and Others)o Application (Research and Clinical)o End User (Research and Academic Institutions, Biotechnology and Pharmaceutical Companies, Corporate Research Organizations, Hospitals and Diagnostic Laboratories, Forensic Laboratories, and Others)o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)• What are the growth opportunities for the companies in the region of their operation?• Who are the leading players with significant offerings to the global genomic data analysis and interpretation market? What is the expected market dominance for each of these leading players?• Which companies are anticipated to be highly disruptive in the future and why?• What are the current unmet needs that are being faced?
Companies Mentioned :
10x Genomics, Inc.Agilent Technologies, Inc.ASURAGEN, INC.Beijing Genomics Institute (BGI) Genomics Co., LtdBio-Rad Laboratories, Inc.DNASTARF. Hoffmann-La Roche LtdGolden Helix, Inc.Illumina, Inc.Oxford Nanopore Technologies, Inc.Pacific Biosciences of California, Inc.Partek Inc.QIAGEN N.V.SoftGenetics, LLCThermo Fisher Scientific Inc.
Press Release :
The global genomic data analysis and interpretation market is projected to reach $2.10 billion by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 10.21% between 2020 and 2030.The comprehensive study of the global genomic data analysis and interpretation market by BIS Research extensively covers the following:• Market numbers on micro-segments that are influencing the market • More than 150 products present in the market• Over 30 brands evaluated • Market share analysis for more than 20 product categories• End-user preference data for over 50 end users• Detailed global and regional market share analysis including the scrutiny of more than 14 countries • Study of data of more than 30 companiesBesides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and a visual dashboard of 150+ products. BIS Research study indicates that decreasing cost of sequencing, global increase in cancer prevalence, and increasing number of population genomics initiative, among others, are fueling the growth of the global genomic data analysis and interpretation market. The market intelligence by BIS Research additionally throws a spotlight on the opportunities existing in the market, such as massive scope for the adoption of genomic data analysis software in the emerging nations and novel diagnostic applications, among others.To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include types of products, genomic platforms, applications, end users, and regions. The application and the region segment have been further sub-segmented to offer an in-depth analysis of the global genomic data analysis and interpretation market.The product and ecosystem analysis of the global market include data analysis on the satisfaction level of different pricing analysis of preferred software solutions. Pertaining to the market segmentation, the product segment is segmented into software and services. The services sub-segment under the product segment has been further classified as licenses and maintenance. The genomic platform segment has been segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, and other platforms. The application segment has been segmented into research and clinical. Research applications have been further segmented into the omics-data analysis, population genomics, annotation and gene expression, and other research applications. The omics-data analysis sub-segment has been further segmented into transcriptomics, microbiomics, proteomics, and others. Additionally, the clinical applications have been further segmented into oncology, rare diseases, infectious diseases, sexual and reproductive health, and other applications. Furthermore, the end user segment has been further segmented into research and academic institutions, biotechnology and biopharmaceutical companies, hospitals and diagnostic laboratories, contract research organizations, forensic laboratories, and other end users.Emphasizing the dominance of the North America region in the global genomic data analysis and interpretation market in 2020 and 2030, Nitish Singh, Analyst at BIS Research, states, " In North America, several emerging and legacy companies are focusing on expanding their respective genomic data analysis software portfolio and are actively involved in developing software new applications, particularly for clinical use. Moreover, a significant infusion of funds for conducting genomic research for enabling precision medicine coupled with a significant decrease in the cost of sequencing has massively promoted the adoption of robust genomic software solutions for data analysis by various end users, further supporting the market growth in the region.”Key insights are drawn from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants, and vendors. The key players profiled in the report include 10x Genomics, Inc., Agilent Technologies, Inc., ASURAGEN INC., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Bio-Rad Laboratories, Inc., DNASTAR, F. Hoffmann-La Roche Ltd., Golden Helix, Inc., Illumina, Inc., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., Partek Inc., QIAGEN N.V., SoftGenetics LLC, and Thermo Fisher Scientific Inc.The study also offers strategic recommendations that can help organizations in tracking various products and trends that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.Who should buy this report?• Developers and manufacturers of robust genomics software solutions, operating in the field of genomics. • Emerging companies in the field of genomic data analysis and interpretation to assess the market situation.How can market intelligence on genomic data analysis and interpretation add value to an organization’s decision-making process?• Aid in product (software) development • Help in targeting a segment for launching a new software • Offer go to market access strategies • Support in diversifying the product portfolio basis risk and progression of underlying genomic technologies • Help in analyzing specifications• Aid in understanding the end-user landscape• Gain holistic views pertaining to the regions and understand the market potential of the countries.• Support in analyzing the competitive landscape to gain an understanding of the business strategies incorporated by the companiesInsightful Questions Covered to Enable Companies take Strategic Decisions• How is genomic data analysis and interpretation revolutionizing the field of research and diagnostics?• What are the major market drivers, challenges, and opportunities in the global genomic data analysis and interpretation market?• What are the underlying structures resulting in the emerging trends within the global genomic data analysis and interpretation market?• How the COVID-19 pandemic impacted the genomic data analysis and interpretation landscape?• What are the key development strategies which are being implemented by the major players in order to sustain in the competitive market?• What are the key regulatory implications in developed and developing regions pertaining to genomics?• What are the potential entry barriers expected to be faced by the companies willing to enter in a particular region? • How is each segment of the market expected to grow during the forecast period from 2020 to 2030, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:o Product Type (Software and Services)o Genomic Platform (NGS, PCR, Microarray, and Others)o Application (Research and Clinical)o End User (Research and Academic Institutions, Biotechnology and Pharmaceutical Companies, Corporate Research Organizations, Hospitals and Diagnostic Laboratories, Forensic Laboratories, and Others)o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)• What are the growth opportunities for the companies in the region of their operation?• Who are the leading players with significant offerings to the global genomic data analysis and interpretation market? What is the expected market dominance for each of these leading players?• Which companies are anticipated to be highly disruptive in the future and why?• What are the current unmet needs that are being faced?
Headline :
Global Genomic Data Analysis and Interpretation Market to Reach $2.10 Billion by 2030
Table of Contents :
Executive Summary 1 Product Definition1.1 Inclusion and Exclusion2 Market Scope2.1 Scope of the Study2.2 Key Questions Answered in the Report2.3 Global Genomic Data Analysis and Interpretation Market: Research Methodology3 Research Methodology3.1 Primary Data Sources3.2 Secondary Data Sources3.3 Market Estimation Model3.4 Criteria for Company Profiling4 Market Overview4.1 Market Definition4.2 Market Footprint and Growth Potential, $Million, 2019-20304.3 COVID-19 Impact on Global Genomic Analysis and Interpretation Market5 Industry Analysis5.1 Overview5.2 Legal Requirements and Framework in U.S.5.3 Legal Requirements and Framework in Europe5.4 Legal Requirements and Framework in Asia-Pacific5.4.1 China5.4.2 Japan6 Market Dynamics6.1 Overview6.2 Iceberg Analysis – Global Genomic Data Analysis and Interpretation Market6.3 Impact Analysis6.4 Market Drivers6.4.1 Decreasing Cost of Sequencing6.4.2 Global Increase in Cancer Prevalence6.4.3 Increasing Number of Population Genomics Initiatives6.5 Market Restraints6.5.1 Lack of High Complexity Genomic Testing Centers in High Potential Markets6.5.2 Challenges Pertaining to Genomic Data Storage6.5.3 Scarcity of Knowledge Dissemination Pertaining to Advanced Diagnostic Capabilities6.6 Market Opportunities6.6.1 Massive Scope for Adoption of Genomic Data Analysis Software in Emerging Nations6.6.2 Novel Diagnostic Applications7 Competitive Landscape7.1 Product Launch and Upgrades7.2 Synergistic Activities7.3 Acquisitions7.4 Market Share Analysis, by Company, 2018-20197.5 Growth Share Analysis7.5.1 Growth Share Analysis (by Company)7.5.2 Growth Share Analysis (by Application)8 Global Genomic Data Analysis and Interpretation Market (by Product Type)8.1 Overview8.2 Software8.3 Services8.3.1 Licenses8.3.2 Maintenance9 Global Genomic Data Analysis and Interpretation Market (by Genomic Platform)9.1 Overview9.2 Next-Generation Sequencing (NGS)9.3 Polymerase Chain Reaction (PCR)9.4 Microarray9.5 Other Genomic Platforms10 Global Genomic Data Analysis and Interpretation Market (by Application)10.1 Overview10.2 Research Applications10.2.1 Omics-Data Analysis10.2.1.1 Transcriptomics10.2.1.2 Microbiomics10.2.1.3 Proteomics10.2.1.4 Other Omics-Data Analysis10.2.2 Population Genomics10.2.3 Annotation and Gene Expression10.2.4 Other Research Applications10.3 Clinical Applications10.3.1 Oncology10.3.2 Rare Diseases10.3.3 Infectious Diseases10.3.4 Sexual and Reproductive Health10.3.5 Other Clinical Applications11 Global Genomic Data Analysis and Interpretation Market (by End User)11.1 Overview11.2 Research and Academic Institutions11.3 Biotechnology and Biopharmaceutical Companies11.4 Hospitals and Diagnostic Laboratories11.5 Contract Research Organizations11.6 Forensic Laboratories11.7 Other End Users12 Global Genomic Data Analysis and Interpretation Market (by Region)12.1 Overview12.2 North America12.2.1 U.S.12.2.2 Canada12.2.3 North America Genomic Data Analysis and Interpretation Market (by Application), 2019-203012.3 Europe12.3.1 Germany12.3.2 U.K.12.3.3 France12.3.4 Italy12.3.5 Spain12.3.6 Netherlands12.3.7 Rest-of-Europe12.3.8 Europe Genomic Data Analysis and Interpretation Market (by Application), 2019-203012.4 Asia-Pacific12.4.1 China12.4.2 Japan12.4.3 India12.4.4 Australia12.4.5 South Korea12.4.6 Rest-of-Asia-Pacific12.4.7 Asia-Pacific Genomic Data Analysis and Interpretation Market (by Application), 2019-203012.5 Latin America12.5.1 Brazil12.5.2 Mexico12.5.3 Rest-of-Latin-America12.5.4 Latin America Genomic Data Analysis and Interpretation Market (by Application), 2019-203012.6 Rest-of-the-World13 Company Profiles13.1 Overview13.2 10x Genomics, Inc.13.2.1 Company Overview13.2.2 Role of 10x Genomics, Inc. in the Global Genomic Data Analysis and Interpretation Market13.2.3 Financials13.2.4 Key Insights About Financial Health of the Company13.2.5 SWOT Analysis13.3 Agilent Technologies, Inc.13.3.1 Company Overview13.3.2 Role of Agilent Technologies, Inc. in the Global Genomic Data Analysis and Interpretation Market13.3.3 Financials13.3.4 Key Insights About Financial Health of the Company13.3.5 SWOT Analysis13.4 ASURAGEN, INC.13.4.1 Company Overview13.4.2 Role of ASURAGEN, INC. in the Global Genomic Data Analysis and Interpretation Market13.4.3 SWOT Analysis13.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd13.5.1 Company Overview13.5.2 Role of Beijing Genomics Institute (BGI) Genomics Co., Ltd in the Global Genomic Data Analysis and Interpretation Market13.5.3 SWOT Analysis13.6 Bio-Rad Laboratories, Inc.13.6.1 Company Overview13.6.2 Role of Bio-Rad Laboratories, Inc. in the Global Genomic Data Analysis and Interpretation Market13.6.3 Financials13.6.4 Key Insights About Financial Health of the Company13.6.5 SWOT Analysis13.7 DNASTAR13.7.1 Company Overview13.7.2 Roles of DNASTAR in the Global Genomic Data Analysis and Interpretation Market13.7.3 SWOT Analysis13.8 F. Hoffmann-La Roche Ltd13.8.1 Company Overview13.8.2 Role of F. Hoffmann-La Roche Ltd. in the Global Genomic Data Analysis and Interpretation Market13.8.3 Financials13.8.4 Key Insights About Financial Health of the Company13.8.5 SWOT Analysis13.9 Golden Helix, Inc.13.9.1 Company Overview13.9.2 Role of Golden Helix, Inc. in the Global Genomic Data Analysis and Interpretation Market13.9.3 SWOT Analysis13.1 Illumina, Inc.13.10.1 Company Overview13.10.2 Role of Illumina, Inc. in the Global Genomic Data Analysis and Interpretation Market13.10.3 Financials13.10.4 Key Insights About Financial Health of the Company13.10.5 SWOT Analysis13.11 Oxford Nanopore Technologies, Inc.13.11.1 Company Overview13.11.2 Role of Oxford Nanopore Technologies, Inc. in the Global Genomic Data Analysis and Interpretation Market13.11.3 SWOT Analysis13.12 Pacific Biosciences of California, Inc.13.12.1 Company Overview13.12.2 Role of Pacific Biosciences of California, Inc. in the Global Genomic Data Analysis and Interpretation Market13.12.3 Financials13.12.4 Key Insights About Financial Health of the Company13.12.5 SWOT Analysis13.13 Partek Inc.13.13.1 Company Overview13.13.2 Role of Partek Inc. in the Global Genomic Data Analysis and Interpretation Market13.13.3 SWOT Analysis13.14 QIAGEN N.V13.14.1 Company Overview13.14.2 Role of QIAGEN N.V. in the Global Genomic Data Analysis and Interpretation Market13.14.3 Financials13.14.4 Key Insights About Financial Health of the Company13.14.5 SWOT Analysis13.15 SoftGenetics, LLC.13.15.1 Company Overview13.15.2 Role of SoftGenetics, LLC in the Global Genomic Data Analysis and Interpretation Market13.15.3 SWOT Analysis13.16 Thermo Fisher Scientific Inc.13.16.1 Company Overview13.16.2 Role of Thermo Fisher Scientific Inc. in the Global Genomic Data Analysis and Interpretation Market13.16.3 Financials13.16.4 Key Insights About Financial Health of the Company13.16.5 SWOT AnalysisList of Tables Table 6.1: Likert ScaleTable 6.2: Impact Analysis of Market DriversTable 6.3: Impact Analysis of Market RestraintsTable 8.1: Examples of Software in the Global Genomic Data Analysis and Interpretation MarketList of Figures Figure 1: Annual NIH Funding in Human Genomics Research, FY2013-FY2018Figure 2: Impact Analysis of Market Drivers and Market Challenges on Global Genomic Data Analysis and Interpretation MarketFigure 3: Global Genomic Data Analysis and Interpretation Market (by Product), $Million, 2019 vs. 2030Figure 4: Global Genomic Data Analysis and Interpretation Market (by Genomic Platform), $Million, 2019 vs. 2030Figure 5: Global Genomic Data Analysis and Interpretation Market (by Application), $Million, 2019 vs. 2030Figure 6: Global Genomic Data Analysis and Interpretation Market (by End User), $Million, 2019 vs. 2030Figure 7: Global Genomic Data Analysis and Interpretation Market SnapshotFigure 2.1: Global Genomics Data Analysis and Interpretation, Market SegmentationFigure 2.2: Global Genomic Data Analysis and Interpretation Market: MethodologyFigure 3.1: Bottom-Up Approach (Segment-Wise Analysis)Figure 3.2: Top-Down Approach (Segment-Wise Analysis)Figure 4.1: Global Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 4.2: Global Genomic Data Analysis and Interpretation Market: COVID-19 ImpactFigure 6.1: Iceberg Analysis – Global Genomic Data Analysis and Interpretation MarketFigure 6.2: Decreasing Cost and Increasing Output (TB) of Genome Sequencing, 2009-2025Figure 6.3: Global Cancer Burden, 2018Figure 7.1: Share of Key Developments and Strategies, January 2017-November 2020Figure 7.2: Share of Product Launch and Upgrades (by Company), January 2017–November 2020Figure 7.3: Share of Synergistic Activities (by Company), January 2017- November 2020Figure 7.4: Share of Acquisitions (by Company), January 2017-November 2020Figure 7.5: Market Share Analysis for Global Genomic Data Analysis and Interpretation Market, 2018 and 2019Figure 7.6: Growth Share Analysis for Global Genomic Data Analysis and Interpretation Market (by Company), 2019Figure 7.7: Growth Share Analysis for Global Genomic Data Analysis and Interpretation Market (by Application), 2018-2019Figure 8.1: Global Genomic Data Analysis and Interpretation Market (by Product Type)Figure 8.2: Global Genomic Data Analysis and Interpretation Market (by Product Type), 2019 and 2030Figure 8.3: Global Genomic Data Analysis and Interpretation Market (Software), $Million, 2019-2030Figure 8.4: Global Genomic Data Analysis and Interpretation Market (by Services), 2019 and 2030Figure 8.5: Global Genomic Data Analysis and Interpretation Market (by Services), $Million, 2019-2030Figure 8.6: Global Genomic Data Analysis and Interpretation Market (Licenses), $Million, 2019-2030Figure 8.7: Global Genomic Data Analysis and Interpretation Market (Maintenance), $Million, 2019-2030Figure 9.1: Global Genomic Data Analysis and Interpretation Market (by Genomic Platform)Figure 9.2: Global Genomic Data Analysis and Interpretation Market (by Genomic Platform), 2019 and 2030Figure 9.3: Primary Data Analysis in NGSFigure 9.4: Secondary Data Analysis in NGSFigure 9.5: Tertiary Data Analysis in NGSFigure 9.6: Global Genomic Data Analysis and Interpretation Market (NGS), $Million, 2019-2030Figure 9.7: Global Genomic Data Analysis and Interpretation Market (PCR), $Million, 2019-2030Figure 9.8: Global Genomic Data Analysis and Interpretation Market (Microarray), $Million, 2019-2030Figure 9.9: Global Genomic Data Analysis and Interpretation Market (Other Genomic Platforms), $Million, 2019-2030Figure 10.1: Global Genomic Data Analysis and Interpretation Market (by Application)Figure 10.2: Global Genomic Data Analysis and Interpretation Market (by Application), $Million, 2019-2030Figure 10.3: Global Genomic Data Analysis and Interpretation Market (by Research Applications), $Million, 2019-2030Figure 10.4: Global Genomic Data Analysis and Interpretation Market (by Omics-Data Analysis), $Million, 2019-2030Figure 10.5: Global Genomic Data Analysis and Interpretation Market (Transcriptomics), $Million, 2019-2030Figure 10.6: Global Genomic Data Analysis and Interpretation Market (Microbiomics), $Million, 2019-2030Figure 10.7: Global Genomic Data Analysis and Interpretation Market (Proteomics), $Million, 2019-2030Figure 10.8: Global Genomic Data Analysis and Interpretation Market (Other Omics-Data Analysis), $Million, 2019-2030Figure 10.9: Global Genomic Data Analysis and Interpretation Market (Population Genomics), $Million, 2019-2030Figure 10.10: Global Genomic Data Analysis and Interpretation Market (Annotation and Gene Expression), $Million, 2019-2030Figure 10.11: Global Genomic Data Analysis and Interpretation Market (Other Research Applications), $Million, 2019-2030Figure 10.12: Global Genomic Data Analysis and Interpretation Market (by Clinical Application), 2019 and 2030Figure 10.13: Global Genomic Data Analysis and Interpretation Market (Oncology), $Million, 2019-2030Figure 10.14: Global Genomic Data Analysis and Interpretation Market (Rare Diseases), $Million, 2019-2030Figure 10.15: Global Genomic Data Analysis and Interpretation Market (Infectious Diseases), $Million, 2019-2030Figure 10.16: Global Genomic Data Analysis and Interpretation Market (Sexual and Reproductive Health), $Million, 2019-2030Figure 10.17: Global Genomic Data Analysis and Interpretation Market (Other Clinical Applications), $Million, 2019-2030Figure 11.1: Global Genomic Data Analysis and Interpretation Market (by End User), $Million, 2019-2030Figure 11.2: Global Genomic Data Analysis and Interpretation Market (Research and Academic Institutions), $Million, 2019-2030Figure 11.3: Global Genomic Data Analysis and Interpretation Market (Biotechnology and Pharmaceutical Companies), $Million, 2019-2030Figure 11.4: Global Genomic Data Analysis and Interpretation Market (Hospitals and Diagnostic Laboratories), $Million, 2019-2030Figure 11.5: Global Genomic Data Analysis and Interpretation Market (Contract Research Organizations), $Million, 2019-2030Figure 11.6: Global Genomic Data Analysis and Interpretation Market (Forensic Laboratories), $Million, 2019-2030Figure 11.7: Global Genomic Data Analysis and Interpretation Market (Other End Users), $Million, 2019-2030Figure 12.1: Global Genomic Data Analysis and Interpretation Market (by Region), $Million, 2019-2030Figure 12.2: Global Genomic Data Analysis and Interpretation Market (by Region), 2019-2030Figure 12.3: North America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.4: North America: Market DynamicsFigure 12.5: North America Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030Figure 12.6: U.S. Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.7: Canada Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.8: North America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030Figure 12.9: Europe Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.10: Europe: Market DynamicsFigure 12.11: Europe Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030Figure 12.12: Germany Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.13: U.K. Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.14: France Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.15: Italy Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.16: Spain Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.17: Netherlands Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.18: Rest-of-Europe Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.19: Europe Genomic Data Analysis and Interpretation Market (by Application), 2019-2030Figure 12.20: Asia-Pacific Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.21: APAC: Market DynamicsFigure 12.22: APAC Genomic Data Analysis and Interpretation Market (by Country), $Million, 2019-2030Figure 12.23: China Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.24: Japan Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.25: India Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.26: Australia Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.27: South Korea Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.28: Rest-of-Asia-Pacific Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.29: Asia-Pacific Genomic Data Analysis and Interpretation Market (by Application), 2019-2030Figure 12.30: Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.31: Latin America: Market DynamicsFigure 12.32: Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.33: Brazil Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.34: Mexico Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.35: Rest-of-Latin America Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 12.36: Latin America Genomic Data Analysis and Interpretation Market (by Application), 2019-2030Figure 12.37: RoW Genomic Data Analysis and Interpretation Market, $Million, 2019-2030Figure 13.1: Total Number of Companies ProfiledFigure 13.2: 10x Genomics, Inc.: Overall Product PortfolioFigure 13.3: 10x Genomics, Inc.: Overall Financials, 2017-2019Figure 13.4: 10x Genomics, Inc.: Revenue (by Segment), 2017-2019Figure 13.5: 10x Genomics, Inc.: Revenue (by Region), 2017-2019Figure 13.6: 10x Genomics, Inc. R&D Expenditure, 2017-2019Figure 13.7: 10x Genomics, Inc.: SWOT AnalysisFigure 13.8: Agilent Technologies, Inc.: Overall Product PortfolioFigure 13.9: Agilent Technologies, Inc.: Overall Financials, 2017-2019Figure 13.10: Agilent Technologies, Inc.: Revenue (by Segment), 2017-2019Figure 13.11: Agilent Technologies, Inc.: Revenue (by Region), 2017-2019Figure 13.12: Agilent Technologies, Inc. R&D Expenditure, 2017-2019Figure 13.13: Agilent Technologies, Inc.: SWOT AnalysisFigure 13.14: ASURAGEN, INC.: Overall Product PortfolioFigure 13.15: ASURAGEN, INC.: SWOT AnalysisFigure 13.16: Beijing Genomics Institute (BGI) Genomics Co., Ltd: Overall Product PortfolioFigure 13.17: Beijing Genomics Institute (BGI) Genomics Co., Ltd.: SWOT AnalysisFigure 13.18: Bio-Rad Laboratories, Inc.: Overall Product PortfolioFigure 13.19: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019Figure 13.20: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019Figure 13.21: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019Figure 13.22: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019Figure 13.23: Bio-Rad Laboratories, Inc.: SWOT AnalysisFigure 13.24: DNASTAR: Overall Product PortfolioFigure 13.25: DNASTAR: SWOT AnalysisFigure 13.26: F. Hoffmann-La Roche Ltd.: Overall Product PortfolioFigure 13.27: F. Hoffmann-La Roche Ltd.: Overall Financials, 2017-2019Figure 13.28: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), 2017-2019Figure 13.29: F. Hoffmann-La Roche Ltd.: Revenue (by Diagnostics), 2017-2019Figure 13.30: F. Hoffmann-La Roche Ltd.: Revenue (by Region), 2017-2019Figure 13.31: F. Hoffmann-La Roche Ltd.: R&D Expenditure, 2017-2019Figure 13.32: F. Hoffmann-La Roche Ltd.: SWOT AnalysisFigure 13.33: Golden Helix, Inc.: Product PortfolioFigure 13.34: Golden Helix, Inc.: SWOT AnalysisFigure 13.35: Illumina, Inc.: Overall Product PortfolioFigure 13.36: Illumina, Inc.: Overall Financials, 2017-2019Figure 13.37: Illumina, Inc.: Revenue (by Segment), 2017-2019Figure 13.38: Illumina, Inc.: Revenue (by Region), 2017-2020Figure 13.39: Illumina, Inc.: R&D Expenditure, 2017-2019Figure 13.40: Illumina, Inc.: SWOT AnalysisFigure 13.41: Oxford Nanopore Technologies, Inc.: Product PortfolioFigure 13.42: Oxford Nanopore Technologies, Inc.: SWOT AnalysisFigure 13.43: Pacific Biosciences of California, Inc.: Overall Product PortfolioFigure 13.44: Pacific Biosciences of California, Inc.: Overall Financials, 2017-2019Figure 13.45: Pacific Biosciences of California, Inc.: Revenue (by Segment), 2017-2019Figure 13.46: Pacific Biosciences of California, Inc.: Revenue (by Region), 2017-2019Figure 13.47: Pacific Biosciences of California, Inc.: R&D Expenditure, 2017-2019Figure 13.48: Pacific Biosciences of California, Inc.: SWOT AnalysisFigure 13.49: Partek Inc.: Product PortfolioFigure 13.50: Partek Inc.: SWOT AnalysisFigure 13.51: QIAGEN N.V.: Product PortfolioFigure 13.52: QIAGEN N.V.: Overall Financials, 2017-2019Figure 13.53: QIAGEN N.V.: Revenue (by Segment), 2017-2019Figure 13.54: QIAGEN N.V.: Revenue (by Region), 2017-2019Figure 13.55: QIAGEN N.V.: R&D Expenditure, 2017-2019Figure 13.56: QIAGEN N.V.: SWOT AnalysisFigure 13.57: SoftGenetics, LLC: Product PortfolioFigure 13.58: SoftGenetics, LLC: SWOT AnalysisFigure 13.59: Thermo Fisher Scientific Inc.: Product PortfolioFigure 13.60: Thermo Fisher Scientific Inc.: Overall Financials: 2017-2020Figure 13.61: Thermo Fisher Scientific Inc.: Sales (by Segment): 2017-2020Figure 13.62: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019Figure 13.63: Thermo Fisher Scientific Inc.: R&D Expenditure, 2017-2019Figure 13.64: Thermo Fisher Scientific Inc.: SWOT Analysis